Neoadjuvant FOLFIRINOX in patients with (borderline) resectable pancreatic cancer: A systematic review and patient-level meta-analysis

Quisette Janssen; Stefan Buettner; Mustafa Suker; Georgios A Margonis; Alessandro Paniccia; Bassel F El-Rayes; Nathan Bahary; Ian Chau; Peter Joel Hosein; Andrew H Ko; Jill Lacy; Nigel Jamieson; Christoph Tinchon; Kyu-Pyo Kim; Marc G Besselink; Johanna Wilmink; Marjolein Y.V Homs; Casper H.J van Eijck; Matthew H. G Katz; Bas Groot Koerkamp

doi:10.1200/JCO.2018.36.15_suppl.e16207

Back

Neoadjuvant FOLFIRINOX in patients with (borderline) resectable pancreatic cancer: A systematic review and patient-level meta-analysis

Journal article

Peer reviewed

Neoadjuvant FOLFIRINOX in patients with (borderline) resectable pancreatic cancer: A systematic review and patient-level meta-analysis

Quisette Janssen, Stefan Buettner, Mustafa Suker, Georgios A Margonis, Alessandro Paniccia, Bassel F El-Rayes, Nathan Bahary, Ian Chau, Peter Joel Hosein, Andrew H Ko, …

Journal of clinical oncology, Vol.36(15_suppl), pp.e16207-e16207

2018-05-20

DOI: https://doi.org/10.1200/JCO.2018.36.15_suppl.e16207

Metrics

7 Record Views

1 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.151 Pancreas & Gall Bladder Disorders; 1.151.395 Pancreatic Cancer
Web Of Science research areas: Oncology
ESI research areas: Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: Neoadjuvant FOLFIRINOX in patients with (borderline) resectable pancreatic cancer: A systematic review and patient-level meta-analysis
Creators: Quisette Janssen - Erasmus MC University Medical Center, Rotterdam, Netherlands
Stefan Buettner - Erasmus MC University Medical Center, Rotterdam, Netherlands
Mustafa Suker - Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, Netherlands
Georgios A Margonis - Division of Surgical Oncology, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD
Alessandro Paniccia - University of Colorado, Aurora, CO
Bassel F El-Rayes - Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
Nathan Bahary - University of Pittsburgh Medical Center Cancer Center Pavilion, Pittsburgh, PA
Ian Chau - Royal Marsden Hospital, London & Sutton, United Kingdom
Peter Joel Hosein - University of Miami Sylvester Comprehensive Cancer Center, Miami, FL
Andrew H Ko - UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
Jill Lacy - Smilow Cancer Hospital, Yale University, New Haven, CT
Nigel Jamieson - West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, United Kingdom
Christoph Tinchon - Department of Hämato-Oncology, Hospital Leoben, Leoben, Austria
Kyu-Pyo Kim - Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
Marc G Besselink - Department of Surgery, Cancer Center Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
Johanna Wilmink - Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
Marjolein Y.V Homs - Erasmus MC, Rotterdam, Netherlands
Casper H.J van Eijck - Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, Netherlands
Matthew H. G Katz - University of Texas MD Anderson Cancer Center, Houston, TX
Bas Groot Koerkamp - Erasmus MC, Rotterdam, Netherlands
Publication Details: Journal of clinical oncology, Vol.36(15_suppl), pp.e16207-e16207
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031599162802976